Search

Search Constraints

You searched for: Author/Creator Vlassenko, Andrei G.

Search Results

1. [IC‐P‐064]: BRAIN AEROBIC GLYCOLYSIS AND AD PATHOLOGY BIOMARKERS IN AUTOSOMAL DOMINANT AD. (1st July 2017)

2. [IC‐P‐166]: UTILITY OF PERFUSION PET MODELS AS MEASURE OF NEURODEGENERATION IN AN AUTOSOMAL DOMINANT ALZHEIMER's DISEASE POPULATION: REPORT FROM THE DIAN STUDY. (1st July 2017)

3. [IC‐P‐205]: BRAIN AEROBIC GLYCOLYSIS AND TAU DEPOSITION WITH [18F]‐AV‐1451 PET. (1st July 2017)

4. [O3–09–05]: BRAIN AEROBIC GLYCOLYSIS AND TAU DEPOSITION WITH [18F]‐AV‐1451 PET. (1st July 2017)

5. [P1–402]: BRAIN AEROBIC GLYCOLYSIS AND AD PATHOLOGY BIOMARKERS IN AUTOSOMAL DOMINANT AD. (1st July 2017)

6. [P2–372]: UTILITY OF PERFUSION PET MODELS AS MEASURES OF NEURODEGENERATION IN AN AUTOSOMAL DOMINANT ALZHEIMER's DISEASE POPULATION: REPORT FROM THE DIAN STUDY. (1st July 2017)

7. Aerobic Glycolysis as a Marker of Tumor Aggressiveness: Preliminary Data in High Grade Human Brain Tumors. (3rd September 2015)

8. Associations between different FDG PET indices and clinical ratings in cognitively unimpaired older adults. (31st December 2021)

9. Characteristics and quantitative impact of off‐target skull binding in tau PET studies of Alzheimer disease. (20th December 2022)

10. Characteristics and quantitative impact of off‐target skull binding in tau PET studies of Alzheimer disease. (20th December 2022)